A Prospective Pilot Study to Investigate the Effectiveness of Quinagolide in the Improvement of Psychological Symptoms Associated with Hyperprolactinaemia. - A)Dopamine agonists and psychological disorders of hyperprolactinaemia

orth Lincolnshire and Goole NHS Foundation Trust0 个研究点目标入组 40 人开始时间: 2010年10月8日最近更新: 2019年12月10日

适应症

试验速览

暂无简介。

•1. Hyperprolactinaemia proven by a prolactin day profile.
•2. Age 18-80
•3. Absence of indication for pituitary surgery.
•4. No prior treatment with Dopamine agonists or off treatment for at least 12 weeks before recruitment.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•1. Ongoing treatment with Dopamine receptor modulating treatment.
•2. Drug induced hyperprolactinaemia.
•3. Stalk syndrome or other (non lactotrophe) active pituitary adenoma.
•4. Pregnancy or breast-feeding.
•5. Prior treatment with dopamine agonists within 12 weeks of recruitment.
•6. Prior pituitary surgery or radiotherapy within one year of recruitment.
•7. Unreplaced pituitary hormone deficiency or uncontrolled hypersecretion state.
•8. Known psychiatric disorder at the time of recruitment.

发起方

orth Lincolnshire and Goole NHS Foundation Trust